Effect of sodium-dependent glucose transporter inhibitors on glycated hemoglobin A1c after 24 weeks in patients with diabetes mellitus: A systematic review and meta-analysis

BACKGROUND: To evaluate dapagliflozin, canagliflozin, empagliflozin, ertugliflozin, and sotagliflozin according to their effect on the glycated hemoglobin A1c (HbA1c) level in patients with type 2 diabetes mellitus. METHODS: The Web of Science, PubMed, Cochrane Library, EMBASE, and Clinical Trials d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mao-Bing, Wang, Hua, Zheng, Qi-Han, Xu, Hua-Lan, Cui, Wei-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793358/
https://www.ncbi.nlm.nih.gov/pubmed/33429775
http://dx.doi.org/10.1097/MD.0000000000024101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793358/
https://www.ncbi.nlm.nih.gov/pubmed/33429775
http://dx.doi.org/10.1097/MD.0000000000024101

Ejemplares similares